Adverse effects of drugs among the elderly should be given special attention when considering a pharmacological intervention. Two recent papers using large electronic health records have explored the impact of drugs with anticholinergic properties. The first, “Associations between Anticholinergic Burden and Adverse Health Outcomes in Parkinson Disease” view here used a HealthFacts database (Cerner Corporation, Kansas…

RSI applies MCDA in high-stakes risk decisions, helping clients define criteria, score options, and test robustness. Its facilitators engage stakeholders in structured deliberation to ensure diverse values are reflected. RSI documents assumptions and uncertainty transparently, providing a defensible foundation for risk-based choices.

RSI offers benchmark dose modeling and reference value derivation as part of its technical modeling and toxicological services. Its staff are experienced with tools like BMDS and PROAST, and apply international best practices for model fitting, critical effect selection, and uncertainty factor justification. RSI documents decisions with transparency, providing clients with not only reference values, but defensible narratives suitable for regulatory or policy use.

RSI is pleased to announce that Norman Shippee recently joined the team as a Climate and Applications Specialist. Dr. Shippee earned his PhD at the University of Victoria. He is an experienced researcher who has focused on establishing stakeholder-defined storm metrics to facilitate safe operations in the marine transportation field. Dr. Shippee has previously provided…

RSI prepares management briefings that translate complex risk data into actionable formats for executives, board members, and public officials. The firm emphasizes strategic relevance, audience-appropriate tone, and decision-aligned framing. RSI ensures consistency with broader communications while enabling real-time risk governance.

RSI facilitates adaptive capacity and vulnerability workshops as part of its work in climate risk, emergency preparedness, and health equity. It ensures participation from affected groups, frontline actors, and institutional partners. RSI captures insights in structured outputs—such as risk maps or priority lists—that inform both planning and resource allocation.

Risk Sciences International (RSI) is pleased to announce in collaboration with the Ontario Centre for Climate Impacts and Adaptation Resources (OCCIAR), the public release of “Best Practices for Consideration of the Effects of Climate Change in Project-Level Assessments”.   The Best Practices document is available at RSI, CONTACT US HERE for a copy. The authoring team…

RSI conducts regulatory scans as a precursor to policy design, compliance assessment, or market entry. Its analysts compile and compare legislative developments, regulatory consultations, and agency guidance across relevant geographies. RSI ensures that scans are updated, scoped, and interpreted to support practical decision-making under dynamic conditions.

To support the quality and defensibility of regulatory decision-making under the Canadian Environmental Protection Act, 1999 (CEPA), Health Canada engaged Risk Sciences International to coordinate an independent external peer review of the Draft Screening Assessment Report (DSAR) for Selected C3-C5 Alcohols, focusing specifically on tert-butanol (CAS RN 75-65-0). This group of substances had been prioritized for risk assessment based on potential human health concerns.